MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,188,000 | +63.4% | 18,876 | +19.4% | 0.04% | +59.3% |
| Q1 2016 | $727,000 | -60.6% | 15,806 | -58.6% | 0.03% | -22.9% |
| Q4 2015 | $1,844,000 | +29.0% | 38,151 | +13.4% | 0.04% | +16.7% |
| Q3 2015 | $1,429,000 | -34.8% | 33,630 | +75.1% | 0.03% | -28.6% |
| Q2 2015 | $2,193,000 | -9.9% | 19,203 | +1.8% | 0.04% | -8.7% |
| Q1 2015 | $2,434,000 | +29.5% | 18,857 | -0.1% | 0.05% | +27.8% |
| Q4 2014 | $1,880,000 | +17.1% | 18,869 | +16.2% | 0.04% | +12.5% |
| Q3 2014 | $1,605,000 | +11.1% | 16,233 | -12.7% | 0.03% | +14.3% |
| Q2 2014 | $1,444,000 | +19.9% | 18,598 | +0.6% | 0.03% | +16.7% |
| Q1 2014 | $1,204,000 | -35.9% | 18,484 | -37.2% | 0.02% | -4.0% |
| Q4 2013 | $1,878,000 | +2.3% | 29,426 | -3.9% | 0.02% | 0.0% |
| Q3 2013 | $1,836,000 | +7.2% | 30,630 | -11.9% | 0.02% | +19.0% |
| Q2 2013 | $1,712,000 | – | 34,787 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |